Takehiro Sando
Impact in
- Hepatology top 2%
- Liver Diseases and Immunity
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Pituitary Gland Disorders and Treatments
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Hepatitis C virus research 1
-
- Inflammatory mediators and NSAID effects 4
- Co-authors
- Kazuwa Nakao (10 shared papers)Yoshihiro Ogawa (3 shared papers)Ichiro Fujisawa (1 shared paper)Hirohiko Yamabe (1 shared paper)Hiroo Imura (1 shared paper)Toshiki Komeda (4 shared papers)Akira Shimatsu (1 shared paper)Naoshi Nishida (2 shared papers)
- Journals
- Journal of Molecular Medicine (2 papers)Hepatology (1 paper)New England Journal of Medicine (1 paper)Biochemical and Biophysical Research Communications (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1 paper)
- Partner nations
- Japan
In The Last Decade
Takehiro Sando
11 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 73
- Hepatology 485
- Endocrinology, Diabetes and Metabolism 279
- Biochemistry 47
- Pharmacology 104
- Cancer Research 81
Countries citing papers authored by Takehiro Sando
This map shows the geographic impact of Takehiro Sando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Sando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Sando more than expected).
Fields of papers citing papers by Takehiro Sando
This network shows the impact of papers produced by Takehiro Sando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Sando. The network helps show where Takehiro Sando may publish in the future.
Co-authors
The 25 scholars most cited alongside Takehiro Sando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 360 | |
| 2 | 2006 | 305 | |
| 3 | Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. | 1994 | 300 |
| 4 | 1995 | 109 | |
| 5 | 1994 | 61 | |
| 6 | 1996 | 47 | |
| 7 | 1994 | 45 | |
| 8 | 1996 | 29 | |
| 9 | 1998 | 18 | |
| 10 | 1996 | 5 | |
| 11 | 1995 | 3 | |
| 12 | 2011 | 0 | |
| 13 | 2021 | 0 |
About Takehiro Sando
Takehiro Sando is a scholar working on Hepatology, Pharmacology, Biochemistry, Endocrinology, Diabetes and Metabolism and Oncology, having authored 13 papers that have together received 1.3k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Cancer-related Molecular Pathways (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Receptor Mechanisms and Signaling (1 paper), Gastrointestinal Bleeding Diagnosis and Treatment (1 paper), Cancer Genomics and Diagnostics (1 paper) and Hepatitis C virus research (1 paper). The work is most often cited by research in Hepatology (485 citations), Endocrinology, Diabetes and Metabolism (279 citations), Biochemistry (47 citations), Pharmacology (104 citations) and Cancer Research (81 citations). Takehiro Sando has collaborated with scholars based in Japan. Frequent co-authors include Kazuwa Nakao, Yoshihiro Ogawa, Ichiro Fujisawa, Hirohiko Yamabe, Hiroo Imura, Toshiki Komeda, Akira Shimatsu, Naoshi Nishida, Masahiro Furukawa and Y Fukuda. Their work appears in journals such as Journal of Molecular Medicine, Hepatology, New England Journal of Medicine, Biochemical and Biophysical Research Communications and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.